Diabetes Treatment Denied in the UK: How to Appeal
Diabetes treatment denied in the UK? Learn NHS CGM rights under NICE NG17, Type 1 vs Type 2 funding differences, private insurer FOS appeals, and Diabetes UK help.
Diabetes affects over five million people in the UK, and access to modern diabetes technology — particularly continuous glucose monitoring — has been a battleground between patient advocates and NHS commissioners for years. Whether you have been refused a Libre sensor, denied access to an insulin pump, or had a private insurer reject a diabetes-related claim, this guide explains your rights and how to fight back.
How Diabetes Treatment Is Funded in the UK
NHS prescribing for Type 1 diabetes: The NHS provides insulin, blood glucose testing strips, and diabetes equipment on prescription at no charge to the patient (prescriptions are free in Scotland, Wales, and Northern Ireland; in England, people with diabetes are exempt from prescription charges). NICE guideline NG17 (updated 2022) now recommends that all people with Type 1 diabetes be offered a real-time CGM device. This is a significant shift — previously CGM was only available to a subset of patients meeting specific criteria.
Flash glucose monitoring (Libre) for Type 1: NHS England committed to providing Libre-style flash glucose monitoring for all eligible Type 1 patients under NG17 recommendations. If your GP or diabetes clinic has refused to prescribe it, you may be entitled to challenge that decision on the basis of NICE guidance.
Type 2 diabetes: Coverage for CGM in Type 2 diabetes is more restricted. NHS funding generally applies to insulin-treated Type 2 patients, not those managed by diet or oral medication alone. This is a common source of confusion and denial.
Private health insurance: Private insurers typically cover diabetes-related hospital admissions — for example, complications requiring surgery or intensive care — but do not routinely cover ongoing technology prescriptions such as CGM sensors or insulin pumps, which are prescription items handled through the NHS.
Common Reasons Diabetes Claims Are Denied
- Not meeting CGM eligibility criteria: Clinicians may apply outdated pre-NG17 criteria and refuse CGM to eligible Type 1 patients.
- ICB not having implemented NG17: Some Integrated Care Boards have been slow to implement NICE guidance, creating a postcode lottery for CGM access.
- Type 2 patient seeking CGM: Private insurers and NHS alike are more restrictive for Type 2 patients, even when CGM would be clinically beneficial.
- Private insurer classifying diabetes as pre-existing: If diabetes was diagnosed before your private policy commenced, the insurer may exclude all related conditions.
- Insulin pump not recommended by diabetes team: NHS insulin pump funding requires a recommendation from a specialist diabetes team, which some patients are denied due to clinic capacity.
How to Appeal a Diabetes Treatment Denial
NHS CGM or insulin pump refusal: Start by asking your GP or diabetes consultant to specify in writing why the treatment is being withheld and which clinical guideline they are following. If the answer contradicts current NICE NG17 guidance, write to the clinical lead at your diabetes centre and your ICB with a copy of the NICE guideline, requesting formal review.
If you are still refused, submit an NHS complaint to your ICB or GP practice. All NHS complaints must receive a written response within 40 working days. If unresolved, escalate to the Parliamentary and Health Service Ombudsman (PHSO).
ClaimBack generates a professional appeal letter in 3 minutes — citing real insurance regulations for your country. Get your free analysis →
Private insurer internal appeal: Submit an appeal in writing, including a letter from your consultant confirming the clinical necessity of the denied treatment. Reference any applicable NICE guidance.
Financial Ombudsman Service (FOS): If your private insurer does not resolve your complaint within 8 weeks, escalate to the FOS at financial-ombudsman.org.uk. The FOS handles private health insurance disputes and can require insurers to fund treatment, reverse exclusions, and pay compensation.
Diabetes UK Advocacy
Diabetes UK (diabetes.org.uk) has been at the forefront of campaigning for equal access to diabetes technology on the NHS. Their helpline at 0345 123 2399 provides free advice on navigating NHS and insurance access problems. Their website includes specific guidance on how to challenge an NHS CGM refusal under NG17.
JDRF UK (jdrf.org.uk) focuses on Type 1 diabetes and publishes regular updates on NHS technology access, clinical trials, and individual advocacy support.
Fight Back With ClaimBack
ClaimBack's free AI tool drafts a professional appeal letter in minutes, tailored to your insurer and denial reason. Don't let a denial be the final word.
Fight your denial at ClaimBack →
Related Reading:
How much did your insurer deny?
Enter your denied claim amount to see what you could recover.
Your insurer is counting on you giving up.
Most people do. Less than 1% of denied claimants ever appeal — even though the majority who do win. ClaimBack was built by people who were denied, who fought back, and who refused to accept "no" from an insurer.
We give you the same appeal arguments that attorneys use — in 3 minutes, for free. Your denial deadline is ticking. Don't let it expire.
Free analysis · No credit card · Takes 3 minutes
Related ClaimBack Guides